Minimizing immunosuppression in hand transplantation

Expert Review of Clinical Immunology

Volumn 8, Issue 7, 2012, Pages 673-684

  Brandacher, Gerald ^a   Lee, W P Andrew ^a   Schneeberger, Stefan ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

hand transplantation; immune regulation; immunosuppression minimization; stem cells; tolerance induction

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOGRAFT; BONE MARROW; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FOLLOW UP; GLYCEMIC CONTROL; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HAND SURGERY; HAND TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MAINTENANCE THERAPY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; QUALITY OF LIFE; REGULATORY T LYMPHOCYTE; REVIEW; RISK BENEFIT ANALYSIS; SKIN BIOPSY; SKIN DEFECT; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; HAND; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; RECONSTRUCTIVE SURGICAL PROCEDURES; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 84867751016     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.54     Document Type: Review

References (95)

1. Gilbert R. Hand transplanted from cadaver is reamputated. Med. Trib. Med. News 5, 23-25 (1964).
2. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast. Reconstr. Surg. 87(3), 401-411 (1991).
3. Jones JW Jr, Ustüner ET, Zdichavsky M et al. Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy. Surgery 126(2), 384-388 (1999). (Pubitemid 29382807)
4. Jones JW, Gruber SA, Barker JH, Breidenbach WC. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. N. Engl. J. Med. 343(7), 468-473 (2000). (Pubitemid 30646486)
5. Margreiter R, Brandacher G, Ninkovic M, Steurer W, Kreczy A, Schneeberger S. A double-hand transplant can be worth the effort! Transplantation 74(1), 85-90 (2002). (Pubitemid 34779216)
6. Lanzetta M, Petruzzo P, Margreiter R et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 79(9), 1210-1214 (2005). (Pubitemid 40664026)
7. Schneeberger S, Zelger B, Ninkovic M, Margreiter R. Transplantation of the hand. Transplant. Rev. 19, 100-107 (2005). (Pubitemid 41194916)
8. Schneeberger S, Ninkovic M, Piza-Katzer H et al. Status 5 years after bilateral hand transplantation. Am. J. Transplant. 6(4), 834-841 (2006). (Pubitemid 43345022)
9. Schneeberger S, Ninkovic M, Gabl M et al. First forearm transplantation: Outcome at 3 years. Am. J. Transplant. 7(7), 1753-1762 (2007). (Pubitemid 46905428)
10. Schuind F, Abramowicz D, Schneeberger S. Hand transplantation: The state-of-the-art. J. Hand Surg. Eur. Vol. 32(1), 2-17 (2007). (Pubitemid 46039409)
11. Petruzzo P, Lanzetta M, Dubernard JM et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 90(12), 1590-1594 (2010).
12. Schneeberger S, Landin L, Jableki J et al.; ESOT CTA Working Group. Achievements and challenges in composite tissue allotransplantation. Transpl. Int. 24(8), 760-769 (2011).
13. Hautz T, Engelhardt TO, Weissenbacher A et al. World experience after more than a decade of clinical hand transplantation: update on the Innsbruck program. Hand Clin. 27(4), 423-31, viii (2011).
14. Tuncer M. Hacettepe University Hospital. Ankara Turkey. Press release, 28 February (2012).
15. Kanitakis J, Jullien D, Petruzzo P et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 76(4), 688-693 (2003). (Pubitemid 37072004)
16. Kaufman CL, Breidenbach W. World experience after more than a decade of clinical hand transplantation: update from the Louisville hand transplant program. Hand Clin. 27(4), 417-21, vii (2011).
17. Starzl TE, Demetris AJ, Trucco M et al. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance. Hepatology 17(6), 1127-1152 (1993). (Pubitemid 23187422)
18. Wekerle T, Sykes M. Mixed chimerism and transplantation tolerance. Annu. Rev. Med. 52, 353-370 (2001). (Pubitemid 32195330)
19. Sykes M. Mixed chimerism and transplant tolerance. Immunity 14(4), 417-424 (2001). (Pubitemid 32441594)
20. Pilat N, Wekerle T. Transplantation tolerance through mixed chimerism. Nat. Rev. Nephrol. 6(10), 594-605 (2010).
21. Fehr T, Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl. Int. 21(12), 1118-1135 (2008).
22. Sykes M. Hematopoietic cell transplantation for tolerance induction: Animal models to clinical trials. Transplantation 87(3), 309-316 (2009).
23. Siemionow M, Nasir S. Impact of donor bone marrow on survival of composite tissue allografts. Ann. Plast. Surg. 60(4), 455-462 (2008). (Pubitemid 351440818)
24. Ciancio G, Miller J, Garcia-Morales RO et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 71(7), 827-835 (2001). (Pubitemid 32417339)
25. Starzl TE. Immunosuppressive therapy and tolerance of organ allografts. N. Engl. J. Med. 358(4), 407-411 (2008). (Pubitemid 351159244)
26. Gorantla VS, Brandacher G, SchneebergerS et al. Favoring the risk-benefit balance for upper extremity transplantation - the Pittsburgh Protocol. Hand Clin. 27(4), 511-520, ix (2011).
27. Rahhal DN, Xu H, Huang WC et al. Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: Preferential localization of chimerism in donor bone. Transplantation 88(6), 773-781 (2009).
28. Klimczak A, Unal S, Jankowska A, Coburn C, Siemionow M. Donor-origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model. Bone Marrow Transplant. 40(4), 373-380 (2007). (Pubitemid 47202423)
29. Fontes P, Rao AS, Demetris AJ et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 344(8916), 151-155 (1994). (Pubitemid 24218877)
30. Salgar SK, Shapiro R, Dodson F et al. Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J. Leukoc. Biol. 66(2), 310-314 (1999). (Pubitemid 29379175)
31. Schneeberger S, Gorantla VS, Hautz T, Pulikkottil B, Margreiter R, Lee WP. Immunosuppression and rejection in human hand transplantation. Transplant. Proc. 41(2), 472-475 (2009).
32. Schneeberger S, Gorantla VS, van Riet RP et al. Atypical acute rejection after hand transplantation. Am. J. Transplant. 8(3), 688-696 (2008). (Pubitemid 351287537)
33. Cendales LC, Kanitakis J, Schneeberger S et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am. J. Transplant. 8(7), 1396-1400 (2008). (Pubitemid 351989486)
34. Hautz T, Zelger B, Grahammer J et al. Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am. J. Transplant. 10(5), 1200-1209 (2010).
35. Hautz T, Zelger B, Brandacher G et al. Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts. Transpl. Int. 25(1), 56-63 (2012).
36. Landin L, Cavadas PC, Ibañez J, Roger I, Vera-Sempere F. CD3+-mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 87(5), 776-781 (2009).
37. Kanitakis J, McGregor B, Badet L et al. Absence of C4d deposition in human composite tissue (hands and face) allograft biopsies: An immunoperoxidase study. Transplantation 84(2), 265-267 (2007). (Pubitemid 47205762)
38. Wu S, Xu H, Chen B et al. Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts. Transplantation 92(6), 627-633 (2011).
39. Black KS, Hewitt CW, Fraser LA et al. Composite tissue (limb) allografts in rats. II. Indefinite survival using low-dose cyclosporine. Transplantation 39(4), 365-368 (1985). (Pubitemid 15107833)
40. Chang J, Davis CL, Mathes DW. The impact of current immunosuppression strategies in renal transplantation on the field of reconstructive transplantation. J. Reconstr. Microsurg. 28(1), 7-19 (2012).
41. Ravindra KV, Ildstad ST. Immunosuppressive protocols and immunological challenges related to hand transplantation. Hand Clin. 27(4), 467-479, ix (2011).
42. Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP. Alemtuzumab induction and prednisonefree maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction - long-term results. Am. J. Transplant. 5(10), 2539-2548 (2005).
43. Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast. Reconstr. Surg. 47(5), 425-431 (1971).
44. Stevens HP, Hovius SE, Heeney JL, van Nierop PW, Jonker M. Immunologic aspects and complications of composite tissue allografting for upper extremity reconstruction: A study in the rhesus monkey. Transplant. Proc. 23(1 Pt 1), 623-625 (1991).
45. Siemionow M, Nasir S. Immunologic responses in vascularized and nonvascularized skin allografts. J. Reconstr. Microsurg. 24(7), 497-505 (2008).
46. Gorantla VS, Demetris AJ. Acute and chronic rejection in upper extremity transplantation: what have we learned? Hand Clin. 27(4), 481-93, ix (2011).
47. Taieb A, Clavijo-Alvarez JA, Hamad GG, Lee WP. Immunologic approaches to composite tissue allograft. J. Hand Surg. Am. 32(7), 1072-1085 (2007). (Pubitemid 47362535)
48. Granger DK, Briedenbach WC, Pidwell DJ, Jones JW, Baxter-Lowe LA, Kaufman CL. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation 74(11), 1624-1630 (2002). (Pubitemid 36014238)
49. Devauchelle B, Badet L, Lengelé B et al. First human face allograft: early report. Lancet 368(9531), 203-209 (2006). (Pubitemid 44037773)
50. Mirowitz SA. Hematopoietic bone marrow within the proximal humeral epiphysis in normal adults: investigation with MR imaging. Radiology 188(3), 689-693 (1993). (Pubitemid 23254586)
51. Brandacher G, Grahammer J, Sucher R, Lee WP. Animal models for basic and translational research in reconstructive transplantation. Birth Defects Res. C. Embryo Today 96(1), 39-50 (2012).
52. Foster RD, Fan L, Neipp M et al. Donor-specific tolerance induction in composite tissue allografts. Am. J. Surg. 176(5), 418-421 (1998). (Pubitemid 29021539)
53. Prabhune KA, Gorantla VS, Maldonado C, Perez-Abadia G, Barker JH, Ildstad ST. Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery 20(8), 441-447 (2000). (Pubitemid 32044153)
54. Pilat N, Hock K, Wekerle T. Mixed chimerism through donor bone marrow transplantation: A tolerogenic cell therapy for application in organ transplantation. Curr. Opin. Organ Transplant. 17(1), 63-70 (2012).
55. Lechler RI, Sykes M, Thomson AW, Turka LA. Organ transplantation - how much of the promise has been realized? Nat. Med. 11(6), 605-613 (2005). (Pubitemid 40868300)
56. Hautz T, Brandacher G, Engelhardt TO et al. How reconstructive transplantation is different from organ transplantation - and how it is not. Transplant. Proc. 43(9), 3504-3511 (2011).
57. Ashton-Chess J, Giral M, Brouard S, Soulillou JP. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 84(10), 1215-1219 (2007). (Pubitemid 351339307)
58. Levitsky J. Operational tolerance: Past lessons and future prospects. Liver Transpl. 17(3), 222-232 (2011).
59. Starzl TE, Lakkis FG. The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology 43(2 Suppl. 1), S151-S163 (2006).
60. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+regulatory T cells. J. Am. Soc. Nephrol. 17(10), 2844-2853 (2006). (Pubitemid 44484674)
61. Starzl TE, Murase N, Abu-Elmagd K et al. Tolerogenic immunosuppression for organ transplantation. Lancet 361(9368), 1502-1510 (2003). (Pubitemid 36566340)
62. Siemionow M, Klimczak A. Tolerance and future directions for composite tissue allograft transplants: Part II. Plast. Reconstr. Surg. 123(1), 7e-17e (2009).
63. Bozulic LD, Breidenbach WC, Ildstad ST. Past, present, and future prospects for inducing donor-specific transplantation tolerance for composite tissue allotransplantation. Semin. Plast. Surg. 21(4), 213-225 (2007).
64. Siemionow MZ, Izycki DM, Zielinski M. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-αβ T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation 76(12), 1662-1668 (2003). (Pubitemid 38032410)
65. Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, Mathes SJ. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers. Transplantation 72(5), 791-797 (2001). (Pubitemid 32879847)
66. Larsen CP, Pearson TC, Adams AB et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am. J. Transplant. 5(3), 443-453 (2005). (Pubitemid 40313335)
67. Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, Wood K. Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 90(12), 1321-1327 (2010).
68. Ezzelarab M, Thomson AW. Tolerogenic dendritic cells and their role in transplantation. Semin. Immunol. 23(4), 252-263 (2011).
69. Pilat N, Sayegh MH, Wekerle T. Costimulatory pathways in transplantation. Semin. Immunol. 23(4), 293-303 (2011).
70. Siemionow M, Klimczak A, Unal S, Agaoglu G, Carnevale K. Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants. Am. J. Transplant. 8(6), 1163-1176 (2008). (Pubitemid 351763693)
71. Hettiaratchy S, Melendy E, Randolph MA et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 77(4), 514-521 (2004). (Pubitemid 38282804)
72. Schneeberger S, Wachtman G, Gorantla VS et al. Utilization of bone marrow cells for immunomodulation in transplantation. Am J Transplant. 10(Suppl. 4), 116 (2010).
73. Brandacher G, Gorantla VS, Schneeberger S et al. Hand/forearm transplantation using a novel cell-based immunomodulatory protocol - experience with five patients. Am. J. Transplant. 11, 190 (2011).
74. Mathes DW, Hwang B, Graves SS et al. Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras. Transplantation 92(12), 1301-1308 (2011).
75. Kawai T, Cosimi AB, Spitzer TR et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358(4), 353-361 (2008). (Pubitemid 351159234)
76. Scandling JD, Busque S, Dejbakhsh-Jones S et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N. Engl. J. Med. 358(4), 362-368 (2008). (Pubitemid 351159235)
77. Leventhal J, Abecassis M, Miller J et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLAmismatched combined kidney and hematopoietic stem cell transplantation. Sci. Transl. Med. 4(124), 124ra28 (2012).
78. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 172(4379), 603-606 (1953).
79. Newton WT, Anderson CB. Planned preimmunization of renal allograft recipients. Surgery 74(3), 430-436 (1973).
80. Salvatierra O Jr, Vincenti F, Amend W et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann. Surg. 192(4), 543-552 (1980). (Pubitemid 11225438)
81. Faendrich F. Cell therapy approaches aiming at minimization of immunosuppression in solid organ transplantation. Curr. Opin. Organ Transplant. 15, 703-708 (2010).
82. Barth RN, Rodriguez ED, Mundinger GS et al. Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. Am. J. Transplant. 11(7), 1407-1416 (2011).
83. Li XC, Turka LA. An update on regulatory T cells in transplant tolerance and rejection. Nat. Rev. Nephrol. 6(10), 577-583 (2010).
84. Matta BM, Castellaneta A, Thomson AW. Tolerogenic plasmacytoid DC. Eur. J. Immunol. 40(10), 2667-2676 (2010).
85. Leonard DA, Gordon CR, Sachs DH, Cetrulo CL Jr. Immunobiology of face transplantation. J. Craniofac. Surg. 23(1), 268-271 (2012).
86. Klimczak A, Agaoglu G, Carnevale KA, Siemionow M. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: Part II. Ann. Plast. Surg. 57(4), 422-430 (2006). (Pubitemid 44450584)
87. Crop M, Baan C, Weimar W, Hoogduijn M. Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl. Int. 22(4), 365-376 (2009).
88. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363(9419), 1439-1441 (2004). (Pubitemid 38586721)
89. Fändrich F. Tolerance in clinical transplantation: Progress, challenge or just a dream? Langenbecks. Arch. Surg. 396(4), 475-487 (2011).
90. Kuo YR, Chen CC, Shih HS et al. Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model. Plast. Reconstr. Surg. 127(2), 569-579 (2011).
91. Mitchell RN. Graft vascular disease: immune response meets the vessel wall. Annu. Rev. Pathol. 4, 19-47 (2009).
92. Baluja P, Haragsim L, Laszik Z. Chronic allograft nephropathy. Adv. Chronic Kidney Dis. 13(1), 56-61 (2006). (Pubitemid 43075445)
93. Unadkat JV, Schneeberger S, Horibe EH et al. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am. J. Transplant. 10(2), 251-261 (2010).
94. Kaufman CL, Ouseph R, Blair B et al. Graft vasculopathy in clinical hand transplantation. Am. J. Transplant. 12(4), 1004-1016 (2012).
95. Diefenbeck M, Nerlich A, Schneeberger S, Wagner F, Hofmann GO. Allograft vasculopathy after allogeneic vascularized knee transplantation. Transpl. Int. 24(1), e1-e5 (2011).